12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's after-market session, several healthcare stocks experienced significant movements. Virpax Pharmaceuticals (VRPX) saw an 18.7% increase, while Aadi Bioscience (AADI) suffered a 59.8% decrease. Other notable gainers include Heart Test Laboratories (HSCS), Delcath Systems (DCTH), Allarity Therapeutics (ALLR), Palisade Bio (PALI), and Dermata Therapeutics (DRMA). On the losing side, Aileron Therapeutics (ALRN), Ontrak (OTRK), Acurx Pharmaceuticals (ACXP), Telesis Bio (TBIO), and RenovoRx (RNXT) saw declines ranging from 7.45% to 16.58%.
December 14, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aadi Bioscience stock decreased by 59.8% to $2.15, with a market cap of $52.7 million.
AADI's dramatic drop in the after-market session could indicate negative news or poor investor confidence, likely leading to a continued short-term downtrend.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Acurx Pharmaceuticals stock fell 9.23% to $3.05, with a market cap of $41.9 million.
The after-market decrease in ACXP's stock price may suggest a bearish short-term outlook, possibly due to market or internal company factors.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 80
NEGATIVE IMPACT
Aileron Therapeutics shares decreased by 16.58% to $4.48, with a market cap of $21.8 million.
The significant decrease in ALRN's stock price may continue in the short term, possibly due to negative market reactions or company-specific issues.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 80
NEGATIVE IMPACT
Ontrak stock fell 10.92% to $0.4, with a market cap of $11.0 million.
OTRK's decline in the after-market session could signal a short-term negative trend, potentially due to adverse investor sentiment.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 80
NEGATIVE IMPACT
RenovoRx stock fell 7.45% to $0.89, with a market value of $9.5 million.
The drop in RNXT's stock price may reflect a negative short-term outlook, potentially due to less favorable investor sentiment or company-specific news.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Telesis Bio shares declined by 7.85% to $0.38, with a market value of $11.2 million.
TBIO's stock price decline in after-market trading could indicate a short-term downward trend, influenced by investor reactions or company news.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Allarity Therapeutics stock increased by 6.59% to $0.58, with a market cap of $2.8 million.
ALLR's after-market gain could indicate a short-term positive trend, potentially due to investor optimism or company developments.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Delcath Systems shares moved upwards by 6.83% to $3.44, with a market value of $75.8 million.
The positive movement in DCTH's stock price could suggest short-term bullish behavior due to favorable market conditions or company news.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Dermata Therapeutics shares rose 6.04% to $0.7, with a market value of $2.4 million.
DRMA's stock price increase could be indicative of a short-term positive trend, reflecting investor confidence or favorable news.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Heart Test Laboratories stock moved upwards by 9.02% to $0.17, with a market cap of $8.3 million.
The increase in HSCS stock price may continue into the short term, reflecting a positive response from the market.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Palisade Bio stock increased by 6.33% to $0.63, with a market value of $5.7 million.
The rise in PALI's stock price suggests a potential short-term upward momentum, possibly driven by positive investor sentiment.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Virpax Pharmaceuticals shares rose 18.7% to $0.29, with a market value of $3.3 million.
The significant after-market rise in VRPX shares suggests positive investor sentiment or reaction to company-specific news, which could lead to a short-term uptrend.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100